Abstract
Advances in genomic technology have generated possibilities for expanding newborn screening from traditional procedures to genomic newborn screening (gNBS). However, before the implementation of gNBS, it is crucial to address various aspects, including parental attitudes, at the national level. With this aim, we analyzed the attitudes and expectations of Slovenian peripartum mothers regarding gNBS and the acceptability of its implementation into the Slovenian health system. A questionnaire-based study was conducted on a convenience sample of 1136 peripartum mothers (a response rate of 84.1%) in a hospital setting in Slovenia. We measured participants’ level of general genetic knowledge, motivation to undergo gNBS, attitude toward its benefits and drawbacks, willingness to participate financially, and factors that would influence their decision to undergo gNBS. Most participants exhibited a positive attitude (83.2%) and were motivated to undertake gNBS (63.4%). They were willing to share genetic data and also contribute to the testing costs. Mothers with better genetic literacy and higher education level, and those with the familial genetic testing experiences were more supportive of gNBS. However, several emotional and socio-ethical concerns were raised regarding how the genetic information would influence family and social life.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The data that support the findings of this study are available upon request.
References
Therrell BL, Padilla CD, Loeber JG, Kneisser I, Saadallah A, Borrajo GJC, et al. Current status of newborn screening worldwide: 2015. Semin Perinatol. 2015;39:171–87.
Battelino T, Kržišnik C, Pavlin K. Early detection and follow-up of children with phenylketonuria in Slovenia. Zdr Vestn. 1994;63:25–8.
Lampret BR, Remec ŽI, Torkar AD, Tanšek MŽ, Šmon A, Koračin V, et al. Expanded newborn screening program in Slovenia using tandem mass spectrometry and confirmatory next generation sequencing genetic testing. Zdr Varst. 2020;59:256–63.
Koracin V, Mlinaric M, Baric I, Brincat I, Djordjevic M, Drole Torkar A, et al. Current status of newborn screening in Southeastern Europe. Front Pediatr. 2021;9:648939.
Sikonja J, Groselj U, Scarpa M, la Marca G, Cheillan D, Kölker S, et al. Towards achieving equity and innovation in newborn screening across Europe. Int J Neonatal Screen. 2022;8:31.
Government Office for Science. Genomics beyond health [Internet]. 2022. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1049628/Genomics_Beyond_Health_Final_Report_Government_Office_for_Science.pdf
Cornwall J, Slatter T, Guilford P, Print CG, Henaghan M, Wee R. Culture, law, ethics, and social implications: is society ready for advanced genomic medicine? Australas Med J. 2014;7:200–2.
Khoury MJ, Gwinn M, Yoon PW, Dowling N, Moore CA, Bradley L. The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med. 2007;9:665–74.
Wright CF, Kroese M. Evaluation of genetic tests for susceptibility to common complex diseases: why, when and how? Hum Genet. 2010;127:125–34.
Etchegary H. Public attitudes toward genetic risk testing and its role in healthcare. Per Med. 2014;11:509–22.
Etchegary H, Pullman D, Simmonds C, Rabie Z, Rahman P. Identifying aspects of public attitudes toward whole genome sequencing to inform the integration of genomics into care. Public Health Genom. 2021;24:229–40.
LePoire E, Basu B, Walker L, Bowen DJ. What do people think about genetics? A systematic review. J Community Genet. 2019;10:171–87.
R Core Team. A language and environment for statistical computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing; 2021. Available from: https://www.R-project.org/
Screen4Rare. A multi-stakeholder initiative launched by IPOPI, ISNS and ESID [Internet]. [cited 2023 Oct 23]. Available from: https://screen4rare.org/
EURORDIS - Rare Diseases Europe. Home [Internet]. [cited 2023 Oct 23]. Available from: https://www.eurordis.org/
EURORDIS. Key principles for newborn screening [Internet]. 2021 [cited 2023 Oct 23]. Available from: https://www.eurordis.org/publications/key-principles-for-newborn-screening/
Etchegary H, Dicks E, Green J, Hodgkinson K, Pullman D, Parfrey P. Interest in newborn genetic testing: a survey of prospective parents and the general public. Genet Test Mol Biomark. 2012;16:353–8.
Waisbren SE, Bäck DK, Liu C, Kalia SS, Ringer SA, Holm IA, et al. Parents are interested in newborn genomic testing during the early postpartum period. Genet Med. 2015;17:501–4.
Moultrie RR, Paquin R, Rini C, Roche MI, Berg JS, Powell CM, et al. Parental views on newborn next generation sequencing: implications for decision support. Matern Child Health J. 2020;24:856–64.
Ballard LM, Horton RH, Fenwick A, Lucassen AM. Genome sequencing in healthcare: understanding the UK general public’s views and implications for clinical practice. Eur J Hum Genet. 2020;28:155–64.
Stark Z, Scott RH. Genomic newborn screening for rare diseases. Nat Rev Genet. 2023;24:1–12.
ASHG - American Society of Human Genetics. Public attitudes toward genetics & genomics research: literature and polling review report [Internet]. 2020. Available from: https://www.ashg.org/wp-content/uploads/2020/01/2020-Public-Views-Genetics-Literature-Review.pdf
Iskrov G, Ivanov S, Wrenn S, Stefanov R. Whole-genome sequencing in newborn screening-attitudes and opinions of Bulgarian pediatricians and geneticists. Front Public Health. 2017;5:308.
Ulm E, Feero WG, Dineen R, Charrow J, Wicklund C. Genetics professionals’ opinions of whole-genome sequencing in the newborn period. J Genet Couns. 2015;24:452–63.
Frost CJ, Andrulis IL, Buys SS, Hopper JL, John EM, Terry MB, et al. Assessing patient readiness for personalized genomic medicine. J Community Genet. 2019;10:109–20.
Bombard Y, Miller FA, Hayeems RZ, Barg C, Cressman C, Carroll JC, et al. Public views on participating in newborn screening using genome sequencing. Eur J Hum Genet. 2014;22:1248–54.
EURORDIS. Juggling care and daily life. The balancing act of the rare disease community. A rare barometer survey [Internet]. 2017. Available from: https://download2.eurordis.org/rbv/2017_05_09_Social%20survey%20leaflet%20final.pdf
European Union Agency for Fundamental Rights. EU Charter of Fundamental Rights [Internet]. 2021 [cited 2023 Oct 23]. Available from: http://fra.europa.eu/en/eu-charter/title/title-iii-equality
United Nations. Convention on the Rights of Persons with Disabilities; Article 5 [Internet]. 2006. Available from: https://social.desa.un.org/issues/disability/crpd/convention-on-the-rights-of-persons-with-disabilities-crpd
Joly Y, Dupras C, Pinkesz M, Tovino SA, Rothstein MA. Looking beyond GINA: policy approaches to address genetic discrimination. Annu Rev Genom Hum Genet. 2020;21:491–507.
Wauters A, Van Hoyweghen I. Global trends on fears and concerns of genetic discrimination: a systematic literature review. J Hum Genet. 2016;61:275–82.
Downie L, Halliday J, Lewis S, Lunke S, Lynch E, Martyn M, et al. Exome sequencing in newborns with congenital deafness as a model for genomic newborn screening: the Baby Beyond Hearing project. Genet Med. 2020;22:937–44.
Pereira S, Smith HS, Frankel LA, Christensen KD, Islam R, Robinson JO, et al. Psychosocial effect of newborn genomic sequencing on families in the BabySeq Project: a randomized clinical trial. JAMA Pediatr. 2021;175:1132–41.
Goldenberg AJ, Dodson DS, Davis MM, Tarini BA. Parents’ interest in whole-genome sequencing of newborns. Genet Med. 2014;16:78–84.
Matro JM, Ruth KJ, Wong YN, McCully KC, Rybak CM, Meropol NJ, et al. Cost sharing and hereditary cancer risk: predictors of willingness-to-pay for genetic testing. J Genet Couns. 2014;23:1002–11.
DeLuca JM. Public attitudes toward expanded newborn screening. J Pediatr Nurs. 2018;38:e19–23.
Ries NM, Hyde-Lay R, Caulfield T. Willingness to pay for genetic testing: a study of attitudes in a Canadian population. Public Health Genom. 2010;13:292–300.
Tarini BA, Simon NJ, Payne K, Gebremariam A, Rose A, Prosser LA. An assessment of public preferences for newborn screening using best-worst scaling. J Pediatr. 2018;201:62–68.e1.
Persky S, Kaphingst KA, Condit CM, McBride CM. Assessing hypothetical scenario methodology in genetic susceptibility testing analog studies: a quantitative review. Genet Med. 2007;9:727–38.
Acknowledgements
The authors would like to thank Mr. Urh Prosenc for his help with editing/translating this paper. The authors also thank the nurses at the maternity wards for their help with surveying the mothers and all mothers for their participation in the study.
Funding
This study was a part of the project/program Gynecology and Reproduction: Genomics for Personalized Medicine and was financially supported by the Slovenian Research Agency (P3-0326).
Author information
Authors and Affiliations
Contributions
BoP and BeP conceived and designed the study. Data was acquired by BeP, GK, and MH, and analyzed by MCS, BoP, BeP, and M.C.S contributed to the interpretation of the results. BeP and MCS wrote the manuscript, while BoP, GK, and MH revised it critically. BoP, BeP, GK, MH, and MCS gave the final approval and are accountable for all aspects of the work.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval
This study protocol was reviewed and approved by Medical Ethics Committee of the Republic of Slovenia (No. 0120-464/2020/5). Written information about the study was provided to those who expressed interest in taking part.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Prosenc, B., Cizek Sajko, M., Kavsek, G. et al. Perception of genomic newborn screening among peripartum mothers. Eur J Hum Genet 32, 163–170 (2024). https://doi.org/10.1038/s41431-023-01497-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41431-023-01497-4